Literature DB >> 19010530

BMP-2 plasmid loaded PLGA/HAp composite scaffolds for treatment of bone defects in nude mice.

Hemin Nie1, Mei-Ling Ho, Chih-Kuang Wang, Chi-Hwa Wang, Yin-Chih Fu.   

Abstract

We studied three different types of scaffolds, encapsulating bone morphogenetic protein-2 (BMP-2) plasmid, in terms of their performances in bone regeneration in nude mice. The plasmid was loaded into fibrous matrices in three different ways: coating of naked DNA (Group A) or DNA/chitosan nanoparticles (Group B) onto scaffolds after fiber fabrication by dripping, and encapsulation of DNA/chitosan nanoparticles into scaffold by mixing them with PLGA/DCM solution before fiber fabrication (Group C). Their individual performances were examined by soft X-ray observation, histological analysis and immunostaining of bone tissue. In addition, the BMP-2 protein concentration and alkaline phosphatase (ALP) activity in serum were monitored. The results revealed that the bioactivity of BMP-2 plasmid released from all three kinds of scaffolds was well maintained; this eventually helped improve the healing of segmental defects in vivo. Interestingly, the three kinds of scaffolds released DNA or DNA nanoparticles in different modes and their performances in bone healing were diverse. These observations demonstrate that the in vivo performance of these newly developed DNA delivery devices correlates well with their in vitro release profiles.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19010530     DOI: 10.1016/j.biomaterials.2008.10.029

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  20 in total

1.  The effect of controlled release of PDGF-BB from heparin-conjugated electrospun PCL/gelatin scaffolds on cellular bioactivity and infiltration.

Authors:  Jongman Lee; James J Yoo; Anthony Atala; Sang Jin Lee
Journal:  Biomaterials       Date:  2012-07-06       Impact factor: 12.479

2.  Tribute to Dr. Marshall Urist: musculoskeletal growth factors: editorial comment.

Authors:  Feza Korkusuz
Journal:  Clin Orthop Relat Res       Date:  2009-12       Impact factor: 4.176

3.  Emulating native periosteum cell population and subsequent paracrine factor production to promote tissue engineered periosteum-mediated allograft healing.

Authors:  Michael D Hoffman; Danielle S W Benoit
Journal:  Biomaterials       Date:  2015-03-18       Impact factor: 12.479

Review 4.  Bioactive electrospun scaffolds delivering growth factors and genes for tissue engineering applications.

Authors:  Wei Ji; Yan Sun; Fang Yang; Jeroen J J P van den Beucken; Mingwen Fan; Zhi Chen; John A Jansen
Journal:  Pharm Res       Date:  2010-11-19       Impact factor: 4.200

5.  A microparticle approach for non-viral gene delivery within 3D human mesenchymal stromal cell aggregates.

Authors:  Andrew S Khalil; Xiaohua Yu; Phuong N Dang; Eben Alsberg; William L Murphy
Journal:  Acta Biomater       Date:  2019-04-18       Impact factor: 8.947

6.  Chitosan-based scaffolds for bone tissue engineering.

Authors:  Sheeny Lan Levengood; Miqin Zhang
Journal:  J Mater Chem B       Date:  2014-06-07       Impact factor: 6.331

7.  A PLG/HAp composite scaffold for lentivirus delivery.

Authors:  R M Boehler; S Shin; A G Fast; R M Gower; L D Shea
Journal:  Biomaterials       Date:  2013-04-18       Impact factor: 12.479

8.  The contribution of plasmid design and release to in vivo gene expression following delivery from cationic polymer modified scaffolds.

Authors:  Misael O Avilés; Chia-Hsuan Lin; Marina Zelivyanskaya; John G Graham; Ryan M Boehler; Phillip B Messersmith; Lonnie D Shea
Journal:  Biomaterials       Date:  2009-11-04       Impact factor: 12.479

Review 9.  Rational design of nanofiber scaffolds for orthopedic tissue repair and regeneration.

Authors:  Bing Ma; Jingwei Xie; Jiang Jiang; Franklin D Shuler; David E Bartlett
Journal:  Nanomedicine (Lond)       Date:  2013-09       Impact factor: 5.307

Review 10.  Electrospun Nanofibers for Cancer Therapy.

Authors:  Huanhuan Luo; Tianyang Jie; Li Zheng; Chenglong Huang; Gang Chen; Wenguo Cui
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.